Breaking News Instant updates and real-time market news.

PETQ

PetIQ

$28.26

1 (3.67%)

, PRSP

Perspecta

$21.64

-0.31 (-1.41%)

19:00
08/14/18
08/14
19:00
08/14/18
19:00

On The Fly: After Hours Movers

UP AFTER EARNINGS: PetIQ (PETQ) up 15.6%... Perspecta (PRSP) up 3.9%... Phoenix New Media (FENG) up 2.7%. ALSO HIGHER: Energen (EGN) up 9.2% after being acquired by Diamondback Energy (FANG), down 5.2%... Adient (ADNT) up 5.5% after entering S&P MidCap 400 Index... Eldorado Resorts (ERI) up 4.2% after entering S&P MidCap 400 Index... Teva (TEVA) up 2.4% after Berkshire Hathaway disclosed increased stake. DOWN AFTER EARNINGS: Casa Systems (CASA) down 25.6%... Agilent (A) down 1.8%... Cree (CREE) down 1.3%. ALSO LOWER: ViewRay (VRAY) down 5.9% after equity offering... Carrizo Oil & Gas (CRZO) down 4.6% after equity offering.

PETQ

PetIQ

$28.26

1 (3.67%)

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

FENG

Phoenix New Media

$4.12

-0.055 (-1.32%)

EGN

Energen

$73.15

1.76 (2.47%)

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

ADNT

Adient

$42.65

0.19 (0.45%)

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

TEVA

Teva

$22.12

0.17 (0.77%)

CASA

Casa Systems

$15.62

-0.17 (-1.08%)

A

Agilent

$66.72

0.77 (1.17%)

CREE

Cree

$50.17

-0.11 (-0.22%)

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

CRZO

Carrizo Oil & Gas

$24.31

0.62 (2.62%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 16

    Sep

  • 15

    Aug

  • 15

    Aug

PETQ PetIQ
$28.26

1 (3.67%)

04/13/18
OPCO
04/13/18
NO CHANGE
Target $28
OPCO
Outperform
PetIQ in the process of building credibility among investors, says Oppenheimer
Oppenheimer analyst Brian Nagel told investors in a research note that he came away from a recent meeting with PetIQ CEO Cord Christensen and VIP Petcare CEO Will Santana "incrementally positive." He said the company, which in the short time since its July 2017 IPO has amounted to "one of the more controversial stories among smaller cap consumer positives," is in the process of building credibility among investors and this process takes time. His Outperform rating and $28 price target reflects his intermediate to longer-term confidence in the PetIQ model and senior management, he said.
04/03/18
RHCO
04/03/18
NO CHANGE
Target $30
RHCO
Buy
PetIQ still has long growth runway, says SunTrust
Following the filing of pro forma financials of PetIQ's VIP business, SunTrust analyst William Chappell, Jr. reiterated his Buy rating and $30 price target on the shares, stating that he still sees the company having a long runway of growth ahead for both its products and services businesses.
11/20/17
JEFF
11/20/17
UPGRADE
Target $26
JEFF
Buy
PetIQ upgraded to Buy from Hold at Jefferies
Jefferies analyst Kevin Grundy upgraded PetIQ to Buy saying the recent pullback in shares provides an attractive entry point. In a non-deal roadshow, management conveyed a "high degree of confidence" in the company's outlook, Grundy tells investors in a research note. He believes the short thesis that has emerged "brings little new" information.
07/02/18
JEFF
07/02/18
NO CHANGE
Target $32
JEFF
Buy
Jefferies remains bullish on PetIQ, boosts price target to $32
Jefferies analyst Kevin Grundy raised his price target for PetIQ (PETQ) to $32 from $30 following a Walmart (WMT) store visit to a new VetIQ Petcare clinic in Lehighton, PA. The analyst sees see PetIQ's retail strategy as sensible given the high margin/return profile of the model. He believes the company's clinic rollout is on track and remains bullish on the stock with a Buy rating.
PRSP Perspecta
$21.64

-0.31 (-1.41%)

06/26/18
VERT
06/26/18
INITIATION
Target $24
VERT
Hold
Perspecta initiated with a Hold at Vertical Research
Vertical Research analyst Krishna Sinha initiated Perspecta with a Hold and $24 price target.
08/09/18
LOOP
08/09/18
INITIATION
Target $23
LOOP
Hold
Perspecta initiated with a Hold at Loop Capital
Loop Capital analyst Joseph Vafi started Perspecta with a Hold rating and $23 price target. Perspecta boasts the highest adjusted EBITDA margins among publicly traded peers, and has the potential for significant cost synergies over the next several years, Vafi tells investors in a research note. However, the analyst believes the shares "could mark time until visibility into revenue acceleration becomes more clear."
08/10/18
08/10/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Stitch Fix (SFIX) initiated with a Buy at SunTrust. 2. Perspecta (PRSP) initiated with a Hold at Loop Capital. 3. EverQuote (EVER) initiated with a Buy at Needham. 4. Sempra Energy (SRE) resumed with an Equal Weight at Morgan Stanley. 5. Aramark (ARMK) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/20/18
WELS
06/20/18
INITIATION
Target $24
WELS
Market Perform
Perspecta initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Ed Caso started Perspecta with a Market Perform rating and $24 price target, citing cost synergies and reliance on historically elusive revenue synergies to meet growth goals.
FENG Phoenix New Media
$4.12

-0.055 (-1.32%)

11/14/17
11/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coca-Cola (KO) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the shares should be a core holding in 2018 and beyond. 2. Deutsche Bank (DB) upgraded to Buy from Hold at HSBC with analyst Alevizos Alevizakos saying the current valuation seemingly ignores the upside inherent in the bank's improved capital position. 3. Famous Dave's (DAVE) upgraded to Buy from Hold at Craig-Hallum with analyst Alex Fuhrman citing the third quarter results beat, refranchising efforts progressing well and further G&A reductions targeted. 4. ADP (ADP) resumed at Equal Weight, up from Underweight, at Morgan Stanley with analyst Danyal Hussain saying he expects ADP to execute with a greater sense of urgency, but there is still "more work to do" and the proxy fight has put a spotlight on some concerns on which investors will remain focused, including margins and potential share losses, he tells investors. 5. Phoenix New Media (FENG) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/17
MACQ
11/14/17
UPGRADE
MACQ
Outperform
Phoenix New Media upgraded to Outperform from Neutral at Macquarie
EGN Energen
$73.15

1.76 (2.47%)

07/12/18
MSCO
07/12/18
DOWNGRADE
MSCO
Equal Weight
Energen downgraded to Equal Weight from Overweight at Morgan Stanley
07/12/18
07/12/18
DOWNGRADE
Target $76

Equal Weight
Energen downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley analyst Drew Venker downgraded Energen to Equal Weight from Overweight citing valuation after the stock's year-to-date outperformance compared to its Permian Basin peers. He lowered his price target on Energen shares to $76 from $93.
07/20/18
WILL
07/20/18
DOWNGRADE
WILL
Hold
Energen downgraded to Hold from Buy at Williams Capital
08/08/18
IMPC
08/08/18
DOWNGRADE
Target $74
IMPC
In-Line
Energen downgraded to In-Line from Outperform at Imperial Capital
Imperial Capital analyst Irene Haas downgraded Energen to In-Line with an unchanged price target of $74. The analyst views the company's Q2 results as "strong" but finds the stock fairly valued at current levels.
FANG Diamondback Energy
$133.75

1.84 (1.39%)

06/20/18
RHCO
06/20/18
NO CHANGE
Target $165
RHCO
Buy
Diamondback Energy pullback offers buying opportunity, says SunTrust
SunTrust analyst Neal Dingmann kept his Buy rating and $165 price target on Diamondback Energy, saying the 7% selloff in the stock price relative to the 2% gain in the Oil&Gas Exploration Sector ETF offers a buying opportunity for investors. The analyst cites the company's recently announced transportation oil agreements to the Gulf Coast to go along with its industry leading operations, adding that 70% of its production will have a fixed discount to Gulf pricing by the end of Q3. Dingmann also states that Diamondback Energy continues to generate industry leading well returns thanks to its strong rates and low operating costs.
08/03/18
GSCO
08/03/18
DOWNGRADE
Target $21
GSCO
Neutral
WPX Energy downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst John Nelson downgraded WPX Energy (WPX) to Neutral and removed the shares from his firm's Conviction List. The analyst believes the company's secular growth outlook remains intact and cites valuation for the downgrade. WPX's valuation is less differentiated at current share levels, and investors should rotate into Diamondback Energy (FANG) and PDC Energy (PDCE), which offer greater upside potential, Nelson tells investors in a research note. The analyst has a $21 price target for WPX shares.
08/14/18
STFL
08/14/18
NO CHANGE
Target $38
STFL
Hold
Viper Energy price target raised to $38 from $32 at Stifel
Stifel analyst Timothy Howard raised his price target for Viper Energy (VNOM) to $38 from $32 after the company posted above-expectation results for Q2 last week, telling investors in a research note that results were less impacted by differentials than had been assumed and given recent commentary by Diamondback Energy (FANG), he believes Viper's exposure is largely capped. Howard maintains a Hold rating on the shares.
06/19/18
JEFF
06/19/18
NO CHANGE
Target $177
JEFF
Buy
Diamondback Energy price target raised to $177 from $170 at Jefferies
Jefferies analyst Mark Lear raised his price target for Diamondback Energy to $177 after a new slide presentation provided detail on the company's new marketing arrangements that assure 70% of gross projected volumes move to the Gulf Coast in the second half of 2018 and 2019. The analyst notes that the deal locks in $5.5 per barrel better pricing in the second half of 2018 and $4 per barrel better in the first half of 2019 compared to his prior estimates. Diamondback's transportation agreements not only assure volume growth through 2019 but also lock in better pricing relative to Midland-Cushing basis futures, Lear tells investors in a research note.He keeps a Buy rating on the shares.
ADNT Adient
$42.65

0.19 (0.45%)

07/31/18
07/31/18
UPGRADE

Overweight
Lear upgraded to Overweight, Adient cut to Underweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Armintas Sinkevicius upgraded Lear (LEA) to Overweight from Equal Weight with the stock trading at a discount to Adient (ADNT), which he also downgraded to Underweight this morning. Lear has a strong operational track record and history of "beat and raise quarters" and Sinkevicius sees upside to estimates and the stock's multiple, he tells investors. Meanwhile, Adient management has recently lowered guidance for the Seating business due to further operational challenges, leaving the analyst seeing limited upside to numbers in the near term, he tells investors. Sinkevicius lowered his price target on Adient shares to $43 from $50 and raised his price target on Lear to $214 from $209.
07/27/18
BARD
07/27/18
UPGRADE
Target $52
BARD
Neutral
Adient upgraded to Neutral at Baird
As reported previously, Baird analyst David Leiker upgraded Adient to Neutral form Underperform. The analyst cited the sequential stability in the company's results, stating that he now sees upside opportunity and downside risk being in balance. Leiker, who said visibility and execution on action plans to improve operational performance are needed to drive more upside, has a $52 price target on Adient shares.
07/31/18
MSCO
07/31/18
DOWNGRADE
MSCO
Underweight
Adient downgraded to Underweight from Equal Weight at Morgan Stanley
07/31/18
07/31/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CBS (CBS) downgraded to Market Perform from Outperform at Cowen with analyst Doug Creutz saying the combination of the legal fight with National Amusements, the potential for a recombination with Viacom (VIAB) and the allegations of sexual harassment against CEO Les Moonves create "too many unquantifiable variables." 2. Caterpillar (CAT) downgraded to Equal Weight from Overweight at Barclays with analyst Adam Seiden saying the company's largest end-markets are no longer at trough. Further, he believes Caterpillar's second half of 2018 price initiatives, directed towards offsetting supply chain and materials cost increases, will limit its ability to expand margins. 3. WisdomTree (WETF) downgraded to Sell from Neutral at Citi with analyst William Katz saying he believes WisdomTree's price-to-earnings multiple can further contract amid mixed flow dynamics and flat earnings growth prospects out to 2020. 4. Adient (ADNT) downgraded to Underweight from Equal Weight at Morgan Stanley. 5. Tupperware Brands (TUP) downgraded to Sell from Hold at Argus with analyst Deborah Ciervo citing the company's disappointing Q2 revenue and reduced outlook for FY18. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ERI Eldorado Resorts
$43.85

0.55 (1.27%)

05/04/18
RHCO
05/04/18
NO CHANGE
Target $49
RHCO
Buy
Eldorado Resorts price target raised to $49 from $37 at SunTrust
SunTrust analyst C. Patrick Scholes raised his price target on Eldorado Resorts to $49 and kept his Buy rating after its Q1 results. Schoes says that despite the earnings miss on weather-related factors, the company's longer term opportunities of a Florida JV and pending purchases look compelling.
05/08/18
NOMU
05/08/18
INITIATION
Target $47
NOMU
Neutral
Eldorado Resorts initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Henry Curtis started Eldorado Resorts with a Neutral rating and $47 price target.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
06/12/18
ROTH
06/12/18
NO CHANGE
Target $60
ROTH
Buy
Eldorado Resorts price target raised to $60 from $56 at Roth Capital
Roth Capital analyst David Bain raised his price target for Eldorado Resorts to $60 from $56, while reiterating a Buy rating on the shares. The analyst believes there is a solid investment case for about $108 per share value based on reasonable CY21 operational and valuation assumptions. Further, Bain believes there is a strong possibility the company will announce another large-scale accretive acquisition within the next 18 to 24-months.
TEVA Teva
$22.12

0.17 (0.77%)

08/02/18
WELS
08/02/18
NO CHANGE
WELS
Market Perform
Mylan may have negative read-through from Teva report, says Wells Fargo
Wells Fargo analyst David Maris highlighted some items in Teva's (TEVA) Q2 earnings report and conference call that he believes may have a negative read-through for Mylan (MYL). For one, Teva management said they expect the North American generics environment to remain challenging. Additionally, Copaxone sales were relatively flat sequentially, which would be a negative for Mylan if expectations are for increased contribution from Mylan's Copaxone generic in Q2. Mylan has a large pipeline of biosimilars and Teva mentioned it is building a facility for biosimilars in Germany, which indicates more competition, added Maris, who keeps a Market Perform rating on Mylan shares.
08/07/18
MZHO
08/07/18
NO CHANGE
Target $27
MZHO
Buy
Teva still confident in migraine drug approval, says Mizuho
Teva traded lower yesterday on news that Celltrion received a Form 483 related to an FDA inspection of its plant, Mizuho analyst Irina Koffler tells investors in a research note. The analyst says Teva management indicated to her that it had knowledge of 483 report at the time of its earnings call and still has confidence in approval of its migraine drug. Koffler keeps a Buy rating on Teva Pharmaceutical with a $27 price target.
08/07/18
STFL
08/07/18
INITIATION
Target $30
STFL
Buy
Alder Biopharmaceuticals initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price target, calling it an attractive, differentiated "pure play" within the migraine antiCGRP prevention market. While Matteis acknowledges it "won't be easy" for Alder to compete with Amgen (AMGN), Novartis (NVS), Eli Lilly (LLY) and Teva (TEVA), he believes the unique profile of eptinezumab remains underappreciated and may allow it to capture meaningful, above consensus share of a large, emerging drug category.
08/08/18
FBCO
08/08/18
NO CHANGE
FBCO
Credit Suisse remains cautiously optimistic on Teva's Fremanezumab approval
Credit Suisse analyst Vamil Divan believes Celltrion press releases and Teva's comments still point to September approval for Fremabezumab. While the analyst would certainly prefer a cleaner story heading into the Action Date, he is comfortable enough with the company comments to maintain a cautiously optimistic view.
CASA Casa Systems
$15.62

-0.17 (-1.08%)

07/31/18
LOOP
07/31/18
NO CHANGE
LOOP
Positive read-across from Harmonic results for Arris/Casa Systems, says Loop Capital
Loop Capital analyst James Kisner notes that Harmonic (HLIT) reported Q2 earnings, with Q3 guidance light but guiding Cable Access to increase quarter over quarter in Q3 and Q4. The analyst generally views the "nice" sequential positive ramp in Harmonic's Cable Access business and expectation for a continued ramp in Q3 and Q4 as a positive indicator for spending trends on broadband infrastructure by cable operators, good news for Arris (ARRS) and Casa Systems (CASA). On the negative side, Kisner pointed out that one could take the "glass half empty" view that Harmonic is taking some share in the cable access space, potentially at the expense of other players, but he believes Harmonic's revenue generation remains relatively small.
07/26/18
07/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Gladstone (GOOD) initiated with an Outperform at Wedbush. 2. TerraForm Power (TERP) initiated with a Market Perform at BMO Capital. 3. Casa Systems (CASA) initiated with a Hold at Loop Capital. 4. Cidara Therapeutics (CDTX) initiated with a Buy at Citi. 5. Inphi (IPHI) initiated with a Buy at Loop Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/18
NORL
07/12/18
NO CHANGE
Target $25
NORL
Outperform
Casa Systems price target lowered to $25 after CFO exit at Northland
Northland analyst Tim Savageaux trimmed his estimates for Casa Systems, which he notes were above consensus, following the announcement that CFO Gary Hall is leaving the company given customer concentration with large MSOs and the potential for volatility. He lowered his price target for Casa shares to $25 from $33 to account for the news and his estimate cuts, though he maintains an Outperform rating on the name.
07/25/18
LOOP
07/25/18
INITIATION
Target $16
LOOP
Hold
Casa Systems initiated with a Hold at Loop Capital
Loop Capital analyst James Kisner initiated Casa Systems with a Hold rating and $16 price target, stating that he has a positive long-term view on the stock but sees some "obvious risks" in the near-term stemming from significant customer concentration, pending customer M&A and the fact that lock-up agreements for 69% of outstanding shares expired on July 25.
A Agilent
$66.72

0.77 (1.17%)

05/15/18
COWN
05/15/18
UPGRADE
COWN
Outperform
Agilent upgraded to Outperform from Market Perform at Cowen
06/08/18
BARD
06/08/18
NO CHANGE
Target $77
BARD
Outperform
Agilent recent weakness a buying opportunity, says Baird
Baird analyst Catherine Ramsey Schulte attended Agilent's analyst day and said her positive outlook on the company remains unchanged. She continues to expect strong core growth and margin expansion to help drive above market performance over the next several years. Schulte said she would use recent weakness as a buying opportunity and reiterated her Outperform rating and $77 price target on Agilent shares.
06/28/18
JPMS
06/28/18
DOWNGRADE
Target $105
JPMS
Underweight
JPMorgan downgrades Varian to Underweight following period of restriction
JPMorgan analyst Tycho Peterson downgraded Varian Medical Systems (VAR) to Underweight from Neutral following a period of restriction. Persistent order growth volatility, a "sluggish" end market and in the near-term and risk from the U.S.-China trade war weigh on the analyst's longer-term outlook for the stock. Varian has a dominant franchise but a mature industry and premium valuation are hard to overlook, Peterson tells investors in a research note. The analyst sees better risk/rewards in other parts of his coverage universe, including tool names Agilent (A), Danaher (DHR) and Thermo Fisher (TMO).
05/15/18
JEFF
05/15/18
NO CHANGE
Target $80
JEFF
Buy
Agilent pullback a buying opportunity, says Jefferies
Jefferies analyst Brandon Couillard recommends using the post-earnings pullback in shares of Agilent Technologies as a buying opportunity. Guidance was maintained, despite dilution from Lasergen, and does not yet capture accretion from the pending AATI deal, Couillard tells investors in a research note. He sees no reason to alter his positive thesis and keeps a Buy rating on Agilent with a slightly reduced price target of $80.
CREE Cree
$50.17

-0.11 (-0.22%)

07/18/18
NOMU
07/18/18
INITIATION
Target $44
NOMU
Neutral
Cree initiated with a Neutral at Nomura Instinet
Nomura initiated Cree with a Neutral and $44 price target.
08/03/18
ADAM
08/03/18
INITIATION
Target $61
ADAM
Buy
Cree initiated with a Buy at Canaccord
Canaccord analyst Jed Dorsheimer initiated Cree with a Buy rating citing the management team's focus on the high power, high value silicon carbide and gallium nitride components and LED components. He believes the company is well positioned in the various secular themes of electrification in the transportation markets as well as high voltage applications in industrial automation. Dorsheimer has a $61 price target on Cree shares.
07/19/18
NOMU
07/19/18
INITIATION
NOMU
Nomura rolls out Analog Semi coverage, names ON top pick
Nomura Instinet analyst Krysten Sciacca last night rolled out coverage on Analog Semiconductors. The analyst expects the group to outperform throughout the remainder of 2018 given its "steadier business models" versus other semi sectors, "strong" free cash flow generation and the "strong" demand coming from the auto and industrial applications. Her top pick is ON Semiconductor (ON), which the analyst initiated with a Buy rating and $30 price target. ON currently trades at a 35% discount to the Analog group, but its multiple should expand as investors come to better appreciate the company's exposure to industrial and auto, Sciacca told investors in a research note. She believes the company's 2020 target model will likely prove conservative. Sciacca also initiated coverage of Microchip (MCHP) with a Buy rating and $110 price target. The stock currently trades at a 22% discount to the comp group, but its "aggressive" de-leveraging, market share gains, and "strong" executional track record warrant the stock returning to its historical five-year average premium of 2%, the analyst contends. She initiated Cree (CREE) with a Hold rating and $44 price target saying the stock is already pricing in tailwinds and assumed coverage of Analog Devices (ADI) with a Neutral rating and $100 price target.
07/19/18
07/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Clorox (CLX) initiated with a Sell at UBS. 2. Cree (CREE) initiated with a Neutral at Nomura Instinet. 3. Paycom (PAYC) initiated with a Buy at Needham. 4. Lonestar Resources (LONE) initiated with a Buy at SunTrust. 5. ON Semiconductor (ON) initiated with a Buy at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
VRAY ViewRay
$9.89

-0.01 (-0.10%)

07/03/18
07/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Veru Inc. (VERU) initiated with a Buy at Maxim. 2. ViewRay (VRAY) initiated with a Buy at Jefferies. 3. MeiraGTx (MGTX) initiated with an Overweight at Barclays. 4. Zafgen (ZFGN) initiated with an Overweight at Piper Jaffray. 5. Eloxx Pharmaceuticals (ELOX) initiated with a Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/25/18
NORL
07/25/18
NO CHANGE
Target $20
NORL
Outperform
Northland 'extremely bullish' on ViewRay changes, ups target to $20
Northland analyst Suraj Kali is "extremely bullish" on the management and board changes announced by ViewRay. The changes signal a new focus on operational execution and potentially a "packaging" of ViewRay for a potential sale in the next few years, Kali tells investors in a research note. The analyst points out that Scott Drake and Keith Grossman bring an M&A perspective to ViewRay having sold their respective companies over the last few years. Kali raised his price target for the shares to $20 from $13 and keeps an Outperform rating on the name. With "Wall Street savvy" operators now the company, the analyst is "more convinced than ever that ViewRay will be another strategic sale in due time."
07/03/18
JEFF
07/03/18
INITIATION
Target $12
JEFF
Buy
ViewRay initiated with a Buy at Jefferies
Jefferies analyst Anthony Petrone started ViewRay with a Buy rating and $12 price target. The analyst believes the company is best positioned to capture early MR-linac adoption given its first mover advantage and growing body of clinical evidence. He believes ViewRay's MRIdian has competitive advantages over Elekta's MR-linac system.
06/18/18
RILY
06/18/18
NO CHANGE
Target $13.5
RILY
ViewRay added to Alpha Generator List at B. Riley FBR
B. Riley FBR analyst Andrew D'Silva added ViewRay to his firm's Alpha Generator List and keeps a Buy rating on the shares with a $13.50 price target. The analyst is positive on the company's install growth.
CRZO Carrizo Oil & Gas
$24.31

0.62 (2.62%)

06/13/18
BMOC
06/13/18
NO CHANGE
Target $33
BMOC
Outperform
Carrizo Oil & Gas price target raised to $33 from $30 at BMO Capital
BMO Capital analyst Dan McSpirit raised his price target on Carrizo Oil to $33 and kept his Outperform rating. The analyst cites the company's relatively lower exposure to the "takeaway tension" in the Permian basin, saying that while the re-rating of the shares is already under way, more upside can be expected from Carrizo's favorable basin differential and its less flow-challenged Eagle Ford operations.
06/28/18
STFL
06/28/18
NO CHANGE
Target $34
STFL
Buy
Carrizo Oil & Gas price target lowered to $34 from $44 at Stifel
Stifel analyst Michael Scialla lowered his Net Asset Value, or NAV, for Carrizo Oil & Gas by 22% as he disaggregated the company's Delaware Basin position into three core operating areas and he also modestly lowered his Wolfcamp A/B type curve. Given the adjustments to his model, Scialla lowered his price target on Carrizo shares to $34 from $44. He keeps a Buy rating on the name, calling the company one of the few mid-cap companies he covers with material exposure to the Eagle Ford, where he believes oil prices could sustain a meaningful advantage over WTI and Midland prices for the next two years.
08/08/18
JRCO
08/08/18
UPGRADE
JRCO
Buy
Carrizo Oil & Gas upgraded to Buy from Accumulate at Johnson Rice
06/07/18
06/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Darden (DRI) upgraded to Buy from Hold at SunTrust with Jake Bartlett citing his view that its multiple will expand with modest comp sales outperformance beyond fiscal 2018, accelerating unit growth, resumed acquisitions and a higher dividend. 2. Wingstop (WING) upgraded to Outperform from Neutral at Wedbush with analyst Nick Setyan saying he believes drivers of same store sales growth and margin upside relative to current consensus 2018 and 2019 estimates exist. 3. LabCorp (LH) upgraded to Overweight from Sector Weight at KeyBanc with analyst Donald Hooker saying he sees LabCorp and Quest Diagnostics (DGX) benefiting over time from their recent contracts with United Healthcare (UNH) and Aetna (AET). 4. Carrizo Oil & Gas (CRZO) upgraded to Buy from Hold at Tudor Pickering. 5. Canadian Solar (CSIQ) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster saying risks from China's new solar policy appear priced in the shares at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SQM

SQM

$37.08

-0.99 (-2.60%)

21:36
04/22/19
04/22
21:36
04/22/19
21:36
Initiation
SQM initiated  »

SQM initiated with a Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

NEE

NextEra Energy

$190.53

1.21 (0.64%)

, UTX

United Technologies

$136.99

-0.01 (-0.01%)

20:25
04/22/19
04/22
20:25
04/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NEE

NextEra Energy

$190.53

1.21 (0.64%)

UTX

United Technologies

$136.99

-0.01 (-0.01%)

KO

Coca-Cola

$47.38

-0.11 (-0.23%)

VZ

Verizon

$58.38

0.33 (0.57%)

PG

Procter & Gamble

$106.04

-0.01 (-0.01%)

LMT

Lockheed Martin

$315.24

0.94 (0.30%)

SHW

Sherwin-Williams

$451.83

-0.61 (-0.13%)

TWTR

Twitter

$34.39

-0.01 (-0.03%)

STT

State Street

$69.92

-0.02 (-0.03%)

CNC

Centene

$48.19

0.04 (0.08%)

FITB

Fifth Third

$27.54

0.02 (0.07%)

NUE

Nucor

$57.00

-0.49 (-0.85%)

DGX

Quest Diagnostics

$85.17

-0.55 (-0.64%)

HAS

Hasbro

$88.02

-0.72 (-0.81%)

HOG

Harley-Davidson

$39.71

-1.2 (-2.93%)

PII

Polaris Industries

$98.93

0.185 (0.19%)

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

GPK

Graphic Packaging

$12.98

0.035 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 02

    May

  • 02

    May

  • 02

    May

  • 04

    May

  • 07

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 11

    Jun

  • 12

    Jun

  • 23

    Jun

  • 13

    Nov

LOGC

LogicBio Therapeutics

$12.28

0.15 (1.24%)

20:16
04/22/19
04/22
20:16
04/22/19
20:16
Hot Stocks
LogicBio Therapeutics' methylmalonic acidemia treatment gets FDA orphan status »

The FDA has grated an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

RBB

RBB Bancorp

$19.18

-0.61 (-3.08%)

19:38
04/22/19
04/22
19:38
04/22/19
19:38
Earnings
RBB Bancorp reports Q1 EPS 51c, consensus 55c »

Reports Q1 NII $25.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 08

    May

BEN

Franklin Resources

$35.04

-0.27 (-0.76%)

19:09
04/22/19
04/22
19:09
04/22/19
19:09
Periodicals
Franklin Resources to reduce workforce by up to 5%, Bloomberg says »

Franklin Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

TSLA

Tesla

$262.90

-10.35 (-3.79%)

18:59
04/22/19
04/22
18:59
04/22/19
18:59
Periodicals
Consumer Reports: Tesla 'Autopilot' is no substitute for a human driver »

Consumer Reports states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

CMRE

Costamare

$5.65

-0.09 (-1.57%)

, WHR

Whirlpool

$139.39

0.35 (0.25%)

18:56
04/22/19
04/22
18:56
04/22/19
18:56
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

CMRE

Costamare

$5.65

-0.09 (-1.57%)

WHR

Whirlpool

$139.39

0.35 (0.25%)

CDNS

Cadence Design

$64.23

0.87 (1.37%)

BEDU

Bright Scholar

$11.38

-0.105 (-0.91%)

RRC

Range Resources

$9.83

0.07 (0.72%)

WAL

Western Alliance

$43.36

-0.89 (-2.01%)

ALDR

Alder Biopharmaceuticals

$12.77

0.1 (0.79%)

ROKU

Roku

$58.19

1.5 (2.65%)

VCYT

Veracyte

$23.04

0.02 (0.09%)

HARP

Harpoon Therapeutics

$11.35

-1.68 (-12.89%)

RMBS

Rambus

$11.80

-0.1 (-0.84%)

GRTS

Gritstone Oncology

$14.57

0.86 (6.27%)

GES

Guess

$16.66

-0.41 (-2.40%)

BHP

BHP Group

$55.14

0.19 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 22

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 04

    May

  • 08

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 22

    May

  • 22

    May

  • 05

    Jun

  • 25

    Apr

PCG

PG&E

$21.45

0.435 (2.07%)

18:52
04/22/19
04/22
18:52
04/22/19
18:52
Hot Stocks
PG&E submits updated financing proposal for safety, reliability investments »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:40
04/22/19
04/22
18:40
04/22/19
18:40
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

PCG

PG&E

$21.45

0.435 (2.07%)

18:39
04/22/19
04/22
18:39
04/22/19
18:39
Hot Stocks
PG&E names Fred Buckman to board, expands board to 15 directors »

PG&E Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$204.62

0.79 (0.39%)

18:36
04/22/19
04/22
18:36
04/22/19
18:36
Periodicals
Apple sued for $1B by teen claiming glitch in facial recognition software »

The report by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 03

    Jun

GOOG

Alphabet

$1,248.96

11.74 (0.95%)

, GOOGL

Alphabet Class A

$1,253.94

12.01 (0.97%)

18:36
04/22/19
04/22
18:36
04/22/19
18:36
Periodicals
Google walkout organizers say company retaliated against them, Wired says »

Two employee activists at…

GOOG

Alphabet

$1,248.96

11.74 (0.95%)

GOOGL

Alphabet Class A

$1,253.94

12.01 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    Apr

  • 14

    May

  • 27

    Oct

CTRA

Contura Energy

$56.27

0.5 (0.90%)

18:16
04/22/19
04/22
18:16
04/22/19
18:16
Hot Stocks
Contura Energy announces departure of CEO Kevin Crutchfield »

Contura Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

BWEN

Broadwind Energy

$1.88

0.06 (3.30%)

18:04
04/22/19
04/22
18:04
04/22/19
18:04
Hot Stocks
Broadwind Energy announces $19.5M tower order »

Broadwind Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 26

    Apr

HLX

Helix Energy

$8.59

0.2 (2.38%)

18:04
04/22/19
04/22
18:04
04/22/19
18:04
Earnings
Helix Energy reports Q1 adjusted EPS 1c, consensus 0c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 15

    May

VBTX

Veritex

$25.92

-0.3 (-1.14%)

18:03
04/22/19
04/22
18:03
04/22/19
18:03
Earnings
Veritex reports Q1 diluted operating EPS 59c, consensus 55c »

Net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 21

    May

BCS

Barclays

$8.70

-0.05 (-0.57%)

18:00
04/22/19
04/22
18:00
04/22/19
18:00
Periodicals
Barclays planning to slash bonuses for investment bankers, FT says »

Barclays plans to crack…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    Jun

NVDA

Nvidia

$188.48

2.22 (1.19%)

, TSLA

Tesla

$262.90

-10.35 (-3.79%)

17:53
04/22/19
04/22
17:53
04/22/19
17:53
Periodicals
Nvidia calls Tesla claims on self-driving 'inaccurate', MarketWatch says »

Tesla (TSLA) claims that…

NVDA

Nvidia

$188.48

2.22 (1.19%)

TSLA

Tesla

$262.90

-10.35 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

  • 22

    May

  • 10

    Jun

EFSC

Enterprise Financial

$42.49

-1.4 (-3.19%)

17:47
04/22/19
04/22
17:47
04/22/19
17:47
Hot Stocks
Enterprise Financial board raised dividend to 15c per share »

The company's Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

EFSC

Enterprise Financial

$42.49

-1.4 (-3.19%)

17:46
04/22/19
04/22
17:46
04/22/19
17:46
Earnings
Enterprise Financial reports Q1 EPS 67c, consensus 91c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

17:45
04/22/19
04/22
17:45
04/22/19
17:45
General news
U.S. tax refunds »

U.S. tax refunds are on…

BPRN

Bank of Princeton

$32.30

(0.00%)

17:43
04/22/19
04/22
17:43
04/22/19
17:43
Earnings
Bank of Princeton reports Q1 EPS 3c, may not compare to consensus 53c »

Reports Q1 NII $9.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

LENS

Presbia

$0.56

-0.0034 (-0.61%)

17:29
04/22/19
04/22
17:29
04/22/19
17:29
Hot Stocks
Presbia discloses staff reduction, search for investor or strategic partner »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$43.36

-0.89 (-2.01%)

17:23
04/22/19
04/22
17:23
04/22/19
17:23
Earnings
Western Alliance reports Q1 adjusted EPS $1.16, consensus $1.09 »

Reports Q1 NII $247.3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

FCF

First Commonwealth

$13.26

-0.22 (-1.63%)

, SAN

Banco Santander

$5.12

-0.015 (-0.29%)

17:21
04/22/19
04/22
17:21
04/22/19
17:21
Hot Stocks
First Commonwealth to acquire 14 branches from Santander »

First Commonwealth…

FCF

First Commonwealth

$13.26

-0.22 (-1.63%)

SAN

Banco Santander

$5.12

-0.015 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.